Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered <i>In Vivo</i> Screening Paradigm for Development of Drugs To Treat Cutaneous Leishmaniasis
Antimicrobial agents and chemotherapy